Clinical Trials Sponsored by Laboratorios Liomont

Total 2071 results

Laboratórios Baldacci S.A

Unknown

Efficacy and Safety of Monocordil Manufactured by Laboratórios Baldacci

Stable Angina

Brazil
Antigen Laboratories, Inc.

Withdrawn

Phase 2 Study in Adults Sensitized to Short Ragweed

Allergic Rhinitis
Paddock Laboratories, Inc.

Completed

A Relative Bioavailability Study of Moexipril HCl 15 mg Tablets Under Fasting Conditions

Healthy

United States
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fasting Conditions

Fasting

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fed Conditions

Fed

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fed Condition

Fasting

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions

Fed

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fasting Condition

Fasting

India
Watson Laboratories, Inc.

Completed

Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris

Acne Vulgaris
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fed Condition

Fed

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fasting Condition

Fasting State

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Indomethacin Extended-Release Capsules 75 mg Under Fed Condition

Fed

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fed Condition

Fed

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Allopurinol 300 mg Tablets USP Under Fasting Condition

Fasting State

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fasting Condition

Fasting State

India
Forest Laboratories
PPD

Terminated

Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI (ASPECT2)

Coronary Artery Disease

United States, Argentina, Belgium, Brazil, Netherlands
Forest Laboratories
Phenomix

Terminated

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone

Diabetes Mellitus, Type II

United States, Belarus, India, Romania, Germany, Lithuania
Ferndale Laboratories, Inc.

Completed

LMX-4 for Postoperative Pain Management in Infants and Children Undergoing Penoplasty Surgery (LMX-4)

Post-Operative Pain

United States
Rovi Pharmaceuticals Laboratories

Completed

Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of a New Ultra Low Molecular Weight Heparin (RO-14) Administered Subcutaneously Increasing Single-doses to Healthy Male Volunteers

Healthy

Spain
Romark Laboratories L.C.

Completed

Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children

Rotavirus Infection | Viral Gastroenteritis Due to Rotavirus

Egypt
Romark Laboratories L.C.

Completed

Nitazoxanide for the Treatment of Prolonged Diarrhea in Children

Diarrhea

Peru
Rovi Pharmaceuticals Laboratories

Completed

Study to Assess Bemiparin Pharmacokinetics in Renal Insufficiency and in the Elderly

Renal Insufficiency

Spain
Rovi Pharmaceuticals Laboratories

Completed

Pharmacokinetic Study of Two Oral Bemiparin Formulations

Healthy

Spain
Rovi Pharmaceuticals Laboratories

Completed

Clinical Trial to Evaluate the Efficacy and Safety of Sodium Bemiparin for Treatment of Diabetic Foot Ulcers

Foot Ulcer, Diabetic

Croatia, Poland, Romania, Russian Federation, Serbia, Spain
Rapid Laboratories Inc.

Unknown

Safety and Efficacy of ADAPTAVIR's Ability to Eliminate Treatment-Resistant Infectious Virus in Peripheral Blood Mononuclear Cells (PBMCs)

HIV Infections

United States
Coria Laboratories, Ltd.

Completed

A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea

Rosacea

United States
Romark Laboratories L.C.

Completed

Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis C (STEALTHC-1)

Chronic Hepatitis C

Egypt
Coria Laboratories, Ltd.

Completed

Evaluation of Tetrix Cream in the Healing of Injured Skin in Subjects With Contact Dermatitis

Healthy

United States
Coria Laboratories, Ltd.

Completed

Clinical Evaluation of the Photoallergy Potential of Atralin Gel

Healthy

United States
Coria Laboratories, Ltd.

Completed

Study to Determine the Phototoxity of Atralin (Tretinoin) Gel, 0.05%

Healthy

United States
Romark Laboratories L.C.

Completed

Study of Nitazoxanide in the Treatment of Chronic Hepatitis C

Chronic Hepatitis C

Egypt
Romark Laboratories L.C.

Completed

Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis

Clostridium Difficile

United States
Romark Laboratories L.C.

Completed

Study of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Hepatitis C

Chronic Hepatitis C

Egypt
Romark Laboratories L.C.

Completed

Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents

Amebiasis

Egypt
AstraZeneca
Laboratorio Progenetica

Completed

Epidemiologic Study of KRAS Mutation in Brazilian Patients With Advanced or Metastatic Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

Brazil
Laboratoires Thea

Recruiting

Comparison of the Performance and Safety of T2769 Versus Vismed® Multi in the Treatment of Moderate to Severe Dry Eye Syndrome

Dry Eye

France
Laboratoires Vivacy

Recruiting

Study of a Novel Hyaluronic Acid Based Gel for Volume Deficiency in the Mid-face (FaceHyal) (FaceHyal)

Aging | Aesthetics | Volume Deficiency in the Mid-Face

France
Laboratoires Thea

Completed

Performance and Safety Assessment of T2769 in Contact Lens Wearers With Dry Eye Symptoms.

Dry Eye

Bulgaria
Laboratoires Thea

Completed

Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients

Ocular Hypertension | Glaucoma

Estonia
Laboratoires Thea

Completed

Systemic Pharmacokinetic Study of T4032 (Unpreserved Bimatoprost 0.01%) Eye Gel Versus Lumigan® 0.01% Eye Drops in 40 Healthy Volunteers

Healthy Volunteers

United States
Laboratoires Vivacy

Completed

Effectiveness and Safety of STYLAGE® M LIDOCAINE Versus STYLAGE® M in Filling Nasolabial Folds (MLIDOM)

Aging

France
Laboratoires FILLMED

Completed

Evaluation of the Long Term Efficacy and Tolerability of ART FILLER® Volume and Lips (AF2)

Aging
Laboratoires Vivacy

Completed

The Evaluation of Efficacy and Safety of Stylage® XL Lidocaïne for the Restoration and/or Augmentation of Facial Volume (BeautyVolume)

Healthy | Aging

France
Laboratoires FILLMED

Completed

Evaluation of the Efficacy and Safety of an Injectable Hyaluronic Acid-based Filler, Art Filler® Volume: Comparative Single-blind Study of the Non-inferiority Versus Juvéderm® Voluma on the Midface, Temple and Jaw-line and Non-comparative Study on the Chin. (AF3) (AF3)

Aging

France
Laboratoires Thea

Completed

Macula Evolution in Patients With AMD Taking Oral Food Supplementation

Age Related Macular Degeneration

France
Vichy Laboratoires

Completed

Anti-acne Efficacy of a Dermo-cosmetic Product Associated With the Fixed Combination Adapalene 0.1%/ Benzoyl Peroxide 2.5% Treatment Versus This Treatment Associated With a Standard Moisturizer in Male and Female Subjects Presenting With Mild to Moderate Acne

Acne

France
Laboratoires Thea

Completed

Efficacy and Tolerability of Blephademodex Wipes

Demodex Blepharitis

Germany
Laboratoires Vivacy

Completed

The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity (HYDRELA)

Aging

France
Laboratoires Thea

Completed

Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose

Primary Open Angle Glaucoma | Ocular Hypertension

France
Laboratoires URGO

Completed

Assessment of Efficacy & Tolerance of Urgo 310 3166 Dressing in Local Venous or Mixed Leg Ulcers (CASSIOPEE)

Ulcers, Leg

France

3

Subscribe